Eugenio Mira

Summary

Affiliation: University of Pavia
Country: Italy

Publications

  1. ncbi Efficacy of selective lymph node dissection in clinically negative neck
    Eugenio Mira
    Department of Otorhinolaryngology, University of Pavia, and IRCCS Policlinico S Matteo, Italy
    Otolaryngol Head Neck Surg 127:279-83. 2002
  2. ncbi Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo
    Eugenio Mira
    Department of Otorhinolaryngology, University of Pavia, I R C C S Policlinico S Matteo, Pavia, Italy
    Eur Arch Otorhinolaryngol 260:73-7. 2003
  3. ncbi Improving the quality of life in patients with vestibular disorders: the role of medical treatments and physical rehabilitation
    E Mira
    Department of Otolaryngology and Head Neck Surgery, University of Pavia and IRCCS Policlinico San Matteo, Pavia, Italy
    Int J Clin Pract 62:109-14. 2008
  4. ncbi Curative and organ-preserving treatment with intra-arterial carboplatin induction followed by surgery and/or radiotherapy for advanced head and neck cancer: single-center five-year results
    Giulia Bertino
    Department of Otolaryngology, University of Pavia IRCCS Policlinico S Matteo, Pavia, Italy
    BMC Cancer 7:62. 2007
  5. ncbi Intratympanic gentamicin in monolateral Meniere's disease: our experience
    Giulia Bertino
    Department of Otolaryngology and Head Neck Surgery, University of Pavia IRCCS Policlinico San Matteo, Pavia, Italy
    Eur Arch Otorhinolaryngol 263:271-5. 2006
  6. ncbi Angioneurotic edema of the upper airways and antihypertensive therapy
    Elisabetta Zanoletti
    Department of Otolaryngology, University of Pavia, I.R.C.C.S. Policlinico S. Matteo, Pavia, Italy
    Acta Otolaryngol 123:960-4. 2003
  7. ncbi Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo
    Roberto Albera
    Second Department of Otorhinolaryngology, San Giovanni Battista Hospital, University of Turin, Turin, Italy
    Acta Otolaryngol 123:588-93. 2003
  8. ncbi 13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group
    Salvatore Toma
    Division of Oncology, Ospedale Casa Sollievo della Sofferenza, I 71013 San Giovanni Rotondo FG, Italy
    Oncol Rep 11:1297-305. 2004
  9. ncbi beta-carotene supplementation in patients radically treated for stage I-II head and neck cancer: results of a randomized trial
    Salvatore Toma
    Department of Oncology, Biology and Genetic, University of Genova, Genova, Italy
    Oncol Rep 10:1895-901. 2003

Detail Information

Publications9

  1. ncbi Efficacy of selective lymph node dissection in clinically negative neck
    Eugenio Mira
    Department of Otorhinolaryngology, University of Pavia, and IRCCS Policlinico S Matteo, Italy
    Otolaryngol Head Neck Surg 127:279-83. 2002
    ..The purpose of this study was to evaluate the efficacy of selective neck dissection (SND) for elective treatment of the clinically negative neck in head and neck squamous cell carcinoma (SCC)...
  2. ncbi Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo
    Eugenio Mira
    Department of Otorhinolaryngology, University of Pavia, I R C C S Policlinico S Matteo, Pavia, Italy
    Eur Arch Otorhinolaryngol 260:73-7. 2003
    ..The effective and safe profile of betahistine in the treatment of vertigo due to peripheral vestibular disorders was confirmed...
  3. ncbi Improving the quality of life in patients with vestibular disorders: the role of medical treatments and physical rehabilitation
    E Mira
    Department of Otolaryngology and Head Neck Surgery, University of Pavia and IRCCS Policlinico San Matteo, Pavia, Italy
    Int J Clin Pract 62:109-14. 2008
    ..A profile of the compound betahistine and its efficacy on QoL indices in the treatment of Menière's disease and other forms of peripheral vertigo is also presented...
  4. ncbi Curative and organ-preserving treatment with intra-arterial carboplatin induction followed by surgery and/or radiotherapy for advanced head and neck cancer: single-center five-year results
    Giulia Bertino
    Department of Otolaryngology, University of Pavia IRCCS Policlinico S Matteo, Pavia, Italy
    BMC Cancer 7:62. 2007
    ..This study evaluated the feasibility, toxicity, response rate and survival of neoadjuvant superselective intra-arterial infusion of high dose carboplatin in advanced head and neck cancer...
  5. ncbi Intratympanic gentamicin in monolateral Meniere's disease: our experience
    Giulia Bertino
    Department of Otolaryngology and Head Neck Surgery, University of Pavia IRCCS Policlinico San Matteo, Pavia, Italy
    Eur Arch Otorhinolaryngol 263:271-5. 2006
    ..The marker of successful gentamicin treatment at short-term is the appearance of signs of curative vertigo and/or vestibular imbalance, and at long-term the disappearance of vertigo attacks...
  6. ncbi Angioneurotic edema of the upper airways and antihypertensive therapy
    Elisabetta Zanoletti
    Department of Otolaryngology, University of Pavia, I.R.C.C.S. Policlinico S. Matteo, Pavia, Italy
    Acta Otolaryngol 123:960-4. 2003
    ..Care should be taken when antihypertensive ACE inhibitor treatments are started and patients should be warned of the potential risk of angioneurotic edema...
  7. ncbi Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo
    Roberto Albera
    Second Department of Otorhinolaryngology, San Giovanni Battista Hospital, University of Turin, Turin, Italy
    Acta Otolaryngol 123:588-93. 2003
    ..It was also established that the DHI is a useful and reliable method for evaluating the efficacy of antivertigo drugs...
  8. ncbi 13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group
    Salvatore Toma
    Division of Oncology, Ospedale Casa Sollievo della Sofferenza, I 71013 San Giovanni Rotondo FG, Italy
    Oncol Rep 11:1297-305. 2004
    ..Only 5 patients (4.1%) reported grade III-IV toxicity. Low-dose of 13-cRA given for 1 year is ineffective as chemoprevention in patients with radically treated HNSCC...
  9. ncbi beta-carotene supplementation in patients radically treated for stage I-II head and neck cancer: results of a randomized trial
    Salvatore Toma
    Department of Oncology, Biology and Genetic, University of Genova, Genova, Italy
    Oncol Rep 10:1895-901. 2003
    ..Our results might support the hypothesis that an adequate beta-carotene treatment could be potentially associated with a decreased risk of death in these patients...